https://www.selleckchem.com/pr....oducts/phycocyanobil
The use of edaravon was significantly effective on the FOUR scale and the dynamics of NSE levels. Conclusions The introduction of edaravone in women with AIS results in positive results already in the acute period of the disease. The use of edaravon was significantly effective on the FOUR scale and the dynamics of NSE levels. The aim To research differences of interleukin (IL)-17 and IL-23 serum levels in patients with Alzheimer's disease, vascular dementia and mild cognitive impairment. Material and methods Serum levels of IL-1